← Back to Clinical Trials
Recruiting NCT07440134

NCT07440134 Visual and Postural Behavior in Myopic and Non-Myopic Teenagers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07440134
Status Recruiting
Phase
Sponsor Essilor International
Condition Teenagers
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-04-03
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 17 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
Ophtalmic measurementsVisuo-postual measurements

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-04-03 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn whether different types of eyeglasses prescription and different types of lenses change how close teenagers hold objects when looking at them up close. The study includes adolescents who are non-myopic and adolescents who are myopic and wear either single-vision lenses or lenses slowing down myopia progression. The main questions it aims to answer are: Do teenagers in these three groups use different average working distances (eye-to-object distance) during everyday tasks? Does wearing Essilor® Stellest® lenses change working distance compared with wearing single-vision lenses? Researchers will compare the three groups to see if their working distances differ. Participants will: Complete an initial optometric eye examination. Come for a second visit where they perform everyday activities while wearing a motion-capture system that measures how they move and how far they hold objects.

Eligibility Criteria

Inclusion Criteria: * Volunteer adolescent, fluent in French, able to follow protocol and read and write * Aged between 12 and 17 years and 6 months * Adolescent with no history, according to the participant and/or their legal representatives, of any pathology, deficit, or disorder that could interfere with visual or cognitive functions. * If the subject wears glasses, they must have an ophthalmic prescription dated within the last year, certifying that a consultation was carried out during the previous year * If the subject wears Essilor® Stellest® 1.0 lenses, they must have worn them for at least two (2) consecutive months prior to inclusion in the study. * If the subject is nearsighted: -6.5D ≤ equivalent sphere ≤ -0.5D with usual correction * If the subject is not nearsighted: -0.5 \< equivalent sphere ≤ +2.5 Exclusion Criteria: * Age ≤ 12 years * Age \> 17 years and 6 months * Pregnant or breastfeeding women (Article L1121-5) * Persons (legal representatives or subjects) deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8 and persons admitted to a health or social care facility for purposes other than research * Participants who are currently excluded from another study * All categories of persons who are particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code) * Declared neurological deficit, in particular a history of epileptic pathology or sensorimotor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders) * Severe declared eye disease involving loss of visual field, such as glaucoma, involving loss of acuity and severe discomfort in low-light or overly bright environments, such as retinitis pigmentosa, or declared and treated dry eye syndrome. * Gougerot-Sjögren syndrome or declared dry eye syndrome * Declared aphakia or pseudophakia (intraocular implant) * Declared systemic pathology, medical treatment, or medication with an effect on vision * People with declared muscle paralysis * Binocular vision problems such as amblyopia, strabismus, or nystagmus * Children of employees or employees of Essilor International, Luxottica, GrandVision, and their subsidiaries * Individuals who have undergone previous refractive surgery, have a history of strabismus surgery, or have a history of any type of eye surgery

Contact & Investigator

Central Contact

David Rio, Phd

✉ riod@essilor.fr

📞 +33(0)155964840

Frequently Asked Questions

Who can join the NCT07440134 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Teenagers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07440134 currently recruiting?

Yes, NCT07440134 is actively recruiting participants. Contact the research team at riod@essilor.fr for enrollment information.

Where is the NCT07440134 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT07440134 clinical trial?

NCT07440134 is sponsored by Essilor International. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology